Tifluadom

Tifluadom

Clinical data
Routes of administration	unknown
ATC code	none
Identifiers
IUPAC name N-[[5-(2-fluorophenyl)-1-methyl-2,3-dihydro-1,4-benzodiazepin-2-yl]methyl]thiophene-3-carboxamide
CAS Number	83386-35-0 N
PubChem (CID)	115208
IUPHAR/BPS	1667
ChemSpider	103084 Y
UNII	TF8X866L0I Y
KEGG	D02694 Y
ChEMBL	CHEMBL169703 Y
ECHA InfoCard	100.073.052
Chemical and physical data
Formula	C22H20FN3OS
Molar mass	393.477 g/mol
3D model (Jmol)	Interactive image
SMILES O=C(NCC1N(c3ccccc3C(=N/C1)\c2ccccc2F)C)c4ccsc4
InChI InChI=1S/C22H20FN3OS/c1-26-16(13-25-22(27)15-10-11-28-14-15)12-24-21(17-6-2-4-8-19(17)23)18-7-3-5-9-20(18)26/h2-11,14,16H,12-13H2,1H3,(H,25,27) Y Key:NPGABYHTDVGGJK-UHFFFAOYSA-N Y
NY (what is this?)

Tifluadom is a benzodiazepine derivative with an unusual activity profile. Unlike most benzodiazepines, tifluadom has no activity at the GABA_A receptor, but instead is a selective agonist for the κ-opioid receptor. In accordance, it has potent analgesic and diuretic effects in animals, and also has sedative effects and stimulates appetite.

While tifluadom has several effects which might have potential uses in medicine such as analgesia and appetite stimulation, κ-opioid agonists tend to produce undesirable effects in humans such as dysphoria and hallucinations, and so these drugs tend to only be used in scientific research. Dysphoric effects are similar to those seen when using other κ-opioid receptor agonists like pentazocine and salvinorin A.